Serum aldosterone is associated with inflammation and aortic stiffness in normotensive overweight and obese young adults

Clinical and Experimental Hypertension

Volumn 34, Issue 1, 2012, Pages 63-70

  Cooper, Jennifer N ^a   Tepper, Ping ^a   Barinas Mitchell, Emma ^a   Woodard, Genevieve A ^a   Sutton Tyrrell, Kim ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aldosterone; Arterial stiffness; Inflammation; Obesity; RAAS

Indexed keywords

ALDOSTERONE; C REACTIVE PROTEIN; SODIUM;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTERIAL STIFFNESS; BODY HEIGHT; BODY MASS; FEMALE; HEART RATE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OBESITY; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SODIUM EXCRETION; WAIST CIRCUMFERENCE;

ADULT; ALDOSTERONE; ANKLE BRACHIAL INDEX; BIOLOGICAL MARKERS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; EXERCISE THERAPY; FEMALE; HUMANS; INFLAMMATION; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PULSATILE FLOW; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84856657394     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2011.618200     Document Type: Review

References (44)

1. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113: 657-663.
2. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients-a longitudinal study. Hypertension 2002; 39:10-15. (Pubitemid 34098081)
3. Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005; 111:3384-3390. (Pubitemid 40923391)
4. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241. (Pubitemid 34163575)
5. Mahmud A. Arterial stiffness and the renin-anglotensin-aldosterone system. J Renin Angiotensin Aldosterone Syst 2004; 5:102-108.
6. Cachofeiro V, Miana M, Heras NDL, et al. Aldosterone and the vascular system. J Steroid Biochem Mol Biol 2008; 109: 331-335.
7. Blacher J, Amah G, Girerd X, et al. Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens 1997; 10:1326-1334. (Pubitemid 28078735)
8. Park S, Kim JB, Shim CY, et al. The influence of serum aldosterone and the aldosterone-renin ratio on pulse wave velocity in hypertensive patients. J Hypertens 2007; 25: 1279-1283. (Pubitemid 46918808)
9. Bernini G, Galetta F, Franzoni F, et al. Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. J Hypertens 2008; 26: 2399-2405.
10. Goodfriend TL, Egan BM, Kelley DE. Aldosterone in obesity. Endocr Res 1998; 24:789-796. (Pubitemid 29016481)
11. Perkins JM, Davis SN. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control. Curr Opin Endocrinol Diabetes Obes 2008; 15:147-152. (Pubitemid 351674095)
12. Lastra-Lastra G, Sowers JR, Restrepo-Erazo K, Manrique-Acevedo C, Lastra-Gonzalez G. Role of aldosterone and angiotensin II in insulin resistance: an update. Clin Endocrinol (Oxf) 2009; 71:1-6.
13. Kraus D, Jager J, Meier B, Fasshauer M, Klein J. Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes. Horm Metab Res 2005; 37:455-459. (Pubitemid 41081228)
14. Duprez DA. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review. J Hypertens 2006; 24:983-991. (Pubitemid 43772300)
15. Singhal A. Endothelial dysfunction: role in obesity-related disorders and the early origins of CVD. Proc Nutr Soc 2005; 64:15-22. (Pubitemid 40685747)
16. Kidambi S, Kotchen JM, Krishnaswami S, Grim CE, Kotchen TA. Aldosterone contributes to blood pressure variance and to likelihood of hypertension in normal-weight and overweight African Americans. Am J Hypertens 2009; 22: 1303-1308.
17. Shapiro Y, Boaz M, Matas Z, Fux A, Shargorodsky M. The association between the renin-angiotensin-aldosterone system and arterial stiffness in young healthy subjects. Clin Endocrinol (Oxf) 2008; 68:510-512. (Pubitemid 351388718)
18. Kimoto E, Shoji T, Shinohara K, et al. Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease. J Am Soc Nephrol 2006; 17:2245-2252. (Pubitemid 44141915)
19. Ellis D, Lloyd C, Becker DJ, Forrest KYZ, Orchard TJ. The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria. Am J Kidney Dis 1996; 27: 809-818. (Pubitemid 26169033)
20. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20:470-475.
21. Warnick GR, Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 1978; 19: 65-76. (Pubitemid 8268303)
22. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476-482.
23. Bondar RJL, Mead DC. Evaluation of glucose-6-phosphate dehydrogenase from leuconostoc mesenteroides in the hexok-inase method for determining glucose in serum. Clin Chem 1974; 20:586-590.
24. Chen H, Sullivan G, Quon MJ. Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 2005; 54: 1914-1925. (Pubitemid 40911252)
25. Lieb W, Larson MG, Benjamin EJ, et al. Multimarker approach to evaluate correlates of vascular stiffness: the Fram-ingham Heart Study. Circulation 2009; 119:37-43.
26. Pratt JH, Rebhun JF, Zhou L, et al. Levels of mineralo-corticoids in whites and blacks. Hypertension 1999; 34: 315-319.
27. Price DA, Fisher ND. The renin-angiotensin system in blacks: active, passive, or what? Curr Hypertens Rep 2003; 5: 225-230.
28. Mahmud A, Feely J. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. Am J Hypertens 2005; 18:50-55. (Pubitemid 40187349)
29. Edwards NC, Steeds RP, Stewart PM, Ferro CJ, Townend JN. Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease a randomized controlled trial. J Am Coll Cardiol 2009; 54:505-512.
30. Joffe HV, Adler GK. Effect of aldosterone and mineralocorti-coid receptor blockade on vascular inflammation. Heart Fail Rev 2005; 10:31-37. (Pubitemid 40895314)
31. Yasmin McEniery CM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004; 24:969-974. (Pubitemid 38620880)
32. Kullo IJ, Seward JB, Bailey KR, et al. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens 2005; 18:1123-1129. (Pubitemid 41139913)
33. Kusche-Vihrog K, Urbanova K, Blanque A, et al. C-reactive protein makes human endothelium stiff and tight. Hypertension 2011; 57:231-237.
34. Brown NJ. Aldosterone and vascular inflammation. Hypertension 2008; 51:161-167. (Pubitemid 351159920)
35. Nguyen XM, Lane J, Smith BR, Nguyen NT. Changes in inflammatory biomarkers across weight classes in a representative US population: a link between obesity and inflammation. J Gastrointest Surg 2009; 13:1205-1212.
36. Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res 1999; 7:355-362. (Pubitemid 129710596)
37. Garg UC, Arnett DK, Folsom AR, et al. Lack of association between platelet glycoprotein IIb/IIIa receptor PlA polymorphism and coronary artery disease or carotid intima-media thickness. Thromb Res 1998; 89:85-89. (Pubitemid 28261282)
38. Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev 2007; 28: 463-491. (Pubitemid 47236334)
39. Hayden MR, Sowers JR. Pancreatic renin-angiotensin-aldosterone system in the cardiometabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr 2008; 3: 129-131.
40. Mosso LM, Carvajal CA, Maiz A, et al. A possible association between primary aldosteronism and a lower beta-cell function. J Hypertens 2007; 25:2125-2130. (Pubitemid 47476311)
41. Cooper SA, Whaley-Connell A, Habibi J, et al. Renin-angiotensin- aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol 2007; 293:H2009-H2023. (Pubitemid 47605846)
42. Lombes M, Oblin ME, Gasc JM, et al. Immunohistochemical and biochemical-evidence for a cardiovascular mineralocorti-coid receptor. Circ Res 1992; 71:503-510.
43. Stowasser M. New perspectives on the role of aldosterone excess in cardiovascular disease. Clin Exp Pharmacol Physiol 2001; 28:783-791. (Pubitemid 32947172)
44. Davies J, Gavin A, Band M, Morris A, Struthers A. Spironolac-tone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients. Br J Clin Pharmacol 2005; 59: 520-523. (Pubitemid 40632241)